Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Junson Capital is a Hong Kong-based global investment management firm specializing in real estate, private equity—including direct investments into life science/biotech—and capital markets. The firm manages over $5 billion in assets and has made at least 14 direct investments across healthcare and biotechnology sectors globally. It is known for its strategic focus on high-growth opportunities within the US, China, Europe, and Asia-Pacific regions. Recent notable investments include Full-Life Technologies (radiopharmaceuticals), Corsair Pharma (ophthalmology), Allotex (corneal tissue engineering), Worg Pharmaceuticals (allergy immunotherapy), MabPlex International (CDMO services), among others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Junson Capital.